Viatris Inc.: Bipolar Disorder trials

The registry lists 18 Bipolar Disorder studies with Viatris Inc. as lead sponsor. 0 are open to participants now and 13 have results posted.

Phase 2 1Phase 3 12Phase 4 1No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I DisorderTerminatedNCT03768726Phase 3Results posted
• Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I DisorderTerminatedNCT02075047Phase 3Results posted
• One-Year Trial of Oral Ziprasidone in Bipolar Patients With Metabolic SyndromeTerminatedNCT01113541Phase 3Results posted
• A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox CapsuleCompletedNCT01053429Results posted
• Non Interventional Study In Bipolar Disorder And Schizophrenia With ZeldoxCompletedNCT00538629Results posted
• Adjunctive Ziprasidone in the Treatment of Bipolar I DepressionCompletedNCT00483548Phase 3Results posted
• Ziprasidone And Olanzapine's Outcomes In ManiaTerminatedNCT00329108Phase 4Results posted
• 3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic SubjectsCompletedNCT00312494Phase 3Results posted
• A Six-week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression.CompletedNCT00282464Phase 3Results posted
• Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)CompletedNCT00280566Phase 3Results posted
• Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)CompletedNCT00265330Phase 3Results posted
• Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)CompletedNCT00257166Phase 3Results posted
• A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I DepressionCompletedNCT00141271Phase 3Results posted
• Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)WithdrawnNCT01124877Phase 3
• Safety And Efficacy Of Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) (Protocol A1281196)WithdrawnNCT01117220Phase 3
• A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic DisordersCompletedNCT00650611Phase 2
• BIMET Study: Evolution of Metabolic and Cardiovascular Risks Factors in Patients With Bipolar DisorderCompletedNCT00584961
• Non-interventional Study of Ziprasidone in the Treatment of Bipolar and Schizoaffective Disorders.CompletedNCT00454883